Valuation Bio-Techne Corporation

Stocks

Market Closed - Nasdaq Other stock markets 04:00:00 2026-06-16 pm EDT			5-day change	1st Jan Change
56.03 ^USD	-0.25%		+2.98%	-4.73%

Jun. 15	Bio-Techne Faces Pressure From Ananym Capital to Explore Sale	MT
Jun. 11	Piper Sandler Initiates Bio-Techne at Neutral With $65 Price Target	MT

Data adjusted to current consolidation scope

Fiscal Period: June	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	17,511	13,600	12,852	11,291	8,066	8,773	-	-
Change	-	-22.34%	-5.5%	-12.14%	-28.57%	8.76%	-	-
Enterprise Value (EV) ¹	17,621	13,609	12,997	11,457	8,249	8,702	8,414	8,095
Change	-	-22.77%	-4.49%	-11.85%	-28%	5.49%	-3.31%	-3.8%
P/E	130x	52.3x	46.4x	68.2x	112x	48.1x	40.5x	33.6x
PBR	11.2x	8.36x	6.72x	5.48x	4.16x	4.07x	3.59x	2.97x
PEG	-	0.6x	7.5x	-1.7x	-2x	0x	2.2x	1.6x
Capitalization / Revenue	18.8x	12.3x	11.3x	9.74x	6.61x	7.26x	6.93x	6.34x
EV / Revenue	18.9x	12.3x	11.4x	9.88x	6.76x	7.2x	6.65x	5.85x
EV / EBITDA	45.7x	30.3x	29.5x	27.9x	19.2x	20.4x	18.8x	16.1x
EV / EBIT	48.7x	32.3x	31.7x	31x	21.5x	22.5x	20.5x	17.5x
EV / FCF	57.2x	48.5x	60.1x	48.5x	32.2x	32.3x	22.9x	24.4x
FCF Yield	1.75%	2.06%	1.66%	2.06%	3.11%	3.09%	4.36%	4.11%
Dividend per Share ²	0.32	0.32	0.32	0.32	0.32	0.32	0.32	0.32
Rate of return	0.28%	0.37%	0.39%	0.45%	0.62%	0.57%	0.57%	0.57%
EPS ²	0.8675	1.658	1.76	1.05	0.46	1.166	1.384	1.67
Distribution rate	36.9%	19.3%	18.2%	30.5%	69.6%	27.4%	23.1%	19.2%
Net sales ¹	931	1,106	1,137	1,159	1,220	1,209	1,266	1,383
EBITDA ¹	385.7	449.3	441	411	429.6	426.2	448.1	501.2
EBIT ¹	362.2	421.3	410.2	370.2	383.6	387.5	411	461.7
Net income ¹	140.4	272.1	285.3	168.1	73.4	184.4	220.2	255.7
Net Debt ¹	109.8	8.881	145.7	166.1	183.8	-70.15	-358.2	-677.7
Reference price ²	112.56	86.66	81.63	71.65	51.45	56.03	56.03	56.03
Nbr of stocks (in thousands)	155,567	156,934	157,437	157,585	156,767	156,569	-	-
Announcement Date	8/5/21	8/4/22	8/8/23	8/7/24	8/6/25	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
BIO-TECHNE CORPORATION	48.05x	7.2x	20.42x	0.57%	8.77B
LONZA GROUP AG	29.85x	5.29x	16.41x	1.1%	43.51B
REVOLUTION MEDICINES, INC.	-19.69x	291.06x	-17.93x	-.--%	33.29B
BEONE MEDICINES AG	39.37x	3.9x	24.99x	-.--%	29.34B
IQVIA HOLDINGS INC.	21.8x	2.52x	10.89x	-.--%	29.9B
CELLTRION, INC.	29.49x	7.59x	19.52x	0.4%	25.42B
MEDPACE HOLDINGS, INC.	27.09x	4.34x	19.75x	-.--%	13.18B
EUROFINS SCIENTIFIC SE	21.78x	1.9x	8.34x	1.22%	12.72B
IONIS PHARMACEUTICALS, INC.	-20.24x	13.32x	-19.83x	-.--%	12.08B
Average	19.72x	37.46x	9.17x	0.37%	23.13B
Weighted average by Cap.	19.27x	50.94x	9.50x	0.38%